Intestinal Brush Border Cells, also known as microvilli cells, are specialized epithelial cells lining the surface of the small intestine, particularly in the villi. These cells play a pivotal role in nutrient absorption and digestion. The defining feature of these cells is the presence of microvilli, microscopic finger-like projections that significantly increase the surface area of the cell membrane. This vast surface area is crucial for maximizing the absorption of nutrients, such as sugars, amino acids, and fatty acids, from the lumen of the intestine into the bloodstream. Brush border cells are rich in digestive enzymes, including sucrase, maltase, and lactase, which facilitate the breakdown of complex carbohydrates into absorbable forms. Additionally, they express transport proteins that facilitate the uptake of nutrients into the cells. The coordinated action of these cells ensures efficient absorption and utilization of nutrients essential for energy and metabolic processes. Brush border cells play a vital role in maintaining overall nutritional homeostasis. Disruptions in their function can lead to malabsorption disorders and nutrient deficiencies. Understanding the physiology of intestinal brush border cells is fundamental to unraveling the complexities of nutrient absorption, digestion, and gastrointestinal health, with implications for clinical interventions in malabsorptive conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States